Publications
84
Citations
951
Est. group size
—
Recurring co-author estimate
Active years
27
Publishing since 2000
Nancy Zhu's research centers on myelodysplastic syndromes (MDS) and related blood disorders, including studies on treatment options like oral and intravenous decitabine, quality of life outcomes, frailty, and diagnostic practices for patients with these conditions. The work spans clinical trials, registry studies, and qualitative research aimed at improving diagnosis and treatment approaches for hematologic disease. Some publications also touch on unrelated topics such as anticoagulation-related bleeding, medical education, and environmental health.
Publication output has fluctuated over the past decade with a notable peak in 2023, and has remained fairly steady overall, averaging about 6-7 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Rate of abnormal uterine bleeding in women on anticoagulation for venous thromboembolism: systematic review and meta-analysis
Journal of Thrombosis and Haemostasis · 2026
- Bridging climate perception, environmental exposure, and social vulnerability: insights from Columbus, Ohio
Environmental Research Communications · 2026
- Teaching resuscitation of critically ill patients to medical learners in the clinical setting – A scoping review
Canadian Journal of Emergency Medicine · 2026
- Point-of-care ultrasound-guided external aortic compression compared to manual external aortic compression: a prospective crossover trial on healthy volunteers
Canadian Journal of Emergency Medicine · 2026
- A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML
Future Oncology · 2025
- Low-dose oral decitabine and cedazuridine among patients with low-risk myelodysplastic syndromes
Blood · 2025
- Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation
BMC Cancer · 2025
- A comparison of overall survival and quality of life in MDS patients treated with azacytidine vs decitabine: A propensity matched registry Study
Blood · 2025
- Grip strength predicts overall survival of patients with myelodysplastic syndrome in a multivariable model
Blood · 2025
- Utility of diagnostic bone marrow examinations for cytopenias and impact on clinical management: A practice audit
Blood · 2025
- External validation of an online predictive model for myelodysplastic syndrome
Blood · 2025
- Improvement in quality of life in MDS patients who become transfusion independent after treatment
Leukemia & lymphoma/Leukemia and lymphoma · 2024
- Improvement in Quality of Life in MDS Patients Who Become Transfusion Independent after Treatment
Blood · 2024
- Impact of Frailty in a Prospective Cohort of Patients with MDS Treated with Hypomethylating Agents
Blood · 2024
- Barriers and Facilitators for Diagnosing and Managing Iron Deficiency Anemia from Healthcare Professionals' Perspective in Alberta, Canada: A Qualitative Study
Blood · 2024
- Blood×23
- Leukemia Research×6
- Clinical Lymphoma Myeloma & Leukemia×4
- British Journal of Haematology×3
- Leukemia×3
- Samir B. Kahwash
Medicine · The Ohio State University
- Helee Desai
Medicine · The Ohio State University
- C. D. Bloomfield
Medicine · The Ohio State University
- Ann-Kathrin Eisfeld
Medicine · The Ohio State University
- Jessica Kohlschmidt
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile